This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Samuel R. Friedman, PhD; Claire Sterk, Drs; Meryl Sufian, PhD
Narcotic and Drug Research Inc New York, NY

Don C. Des Jarlais, PhD
Beth Israel Medical Center Boston, Mass

JAMA. 1989;262(11):1467.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor. —

Intravenous drug users (IVDUs) are the second largest group of persons at risk for acquired immunodeficiency syndrome in the United States and Europe, and are the major source of heterosexually transmitted acquired immunodeficiency syndrome in the United States and Europe.¹ Many risk-reduction campaigns in the United States emphasize getting IVDUs to use bleach to decontaminate injection equipment. As a result, bleach has become widely used among IVDUs.

In vitro studies show that bleach in a 1:10 dilution with water effectively kills human immunodeficiency virus² and also inactivates human immunodeficiency virus infection in white blood cells.^3,4 The use of bleach to disinfect injection equipment also appears to be relatively safe.⁵ No studies have yet demonstrated whether bleach use affects seroprevalence rates among IVDUs or whether persons who inject different drugs might be more or less likely to use bleach consistently. Two studies^6,7 . . . [Full Text PDF of this Article]

Footnotes
Edited by Drummond Rennie, MD, Deputy Editor (West).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?